CINCINNATI–(BUSINESS WIRE)–Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that
it will report its fourth quarter and fiscal year 2018 financial results
after the market close on Monday, February 25, 2019. The Company will
host a conference call the following morning, Tuesday, February 26,
2019, at 9:00 a.m. ET to discuss these results.
To participate in the conference call, dial 800-219-7113 (domestic) or
574-990-1030 (international) using the passcode 5975717.
To access the conference call via webcast, visit the “Investors” section
of Medpace’s website at investor.medpace.com.
The webcast replay of the call will be available at the same site
approximately one hour after the end of the call.
A supplemental slide presentation will also be available at the
“Investors” section of Medpace’s website prior to the start of the call.
A recording of the call will be available from 12:00 p.m. ET on Tuesday,
February 26, 2019 until 12:00 p.m. ET on Tuesday, March 12, 2019. To
hear this recording, dial 855-859-2056 (domestic) or 404-537-3406
(international) using the passcode 5975717.
Medpace is a scientifically-driven, global, full-service clinical
contract research organization (CRO) providing Phase I-IV clinical
development services to the biotechnology, pharmaceutical and medical
device industries. Medpace’s mission is to accelerate the global
development of safe and effective medical therapeutics through its
high-science and disciplined operating approach that leverages
regulatory and therapeutic expertise across all major areas including
oncology, cardiology, metabolic disease, endocrinology, central nervous
system and anti-viral and anti-infective. Headquartered in Cincinnati,
Ohio, Medpace employs approximately 2,900 people across 36 countries.
Medpace Holdings, Inc.